MedPath

Collagenase in the Treatment of Cellulite

Phase 2
Conditions
Cellulite
Registration Number
NCT00261144
Lead Sponsor
Stony Brook University
Brief Summary

The purpose of this study is to determine if collagenase injection will reduce or eliminate the appearance of cellulite of the thigh.

Detailed Description

This is an open label study of collagenase injection therapy for reduction and/or elimination of cellulite of the posterolateral thighs.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 10 x 10 cm area of cellulite of the posterolateral thigh(s)
Read More
Exclusion Criteria
  • any chronic, serious or uncontrolled medical condition
  • inability to conform to study visits (12-15 per year)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Reduction and/or elimination of cellulite in the posterolateral thigh6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dept. Orthopaedics, SUNY Stony Brook

🇺🇸

Stony Brook, New York, United States

© Copyright 2025. All Rights Reserved by MedPath